ArticleEMBO molecular medicine2022

miR-181a/b downregulation: a mutation-independent therapeutic approach for inherited retinal diseases.

Sabrina Carrella et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.